The role of estrogen in the regulation of hypothalamic beta-endorphin
hormone secretion is studied by determining beta-endorphin concentrati
on in pituitary portal plasma of ovariectomized rats in the presence o
r absence of this steroid and/or the opioid antagonist naloxone. Twent
y-six hours following s.c. injection of 10 mu g estradiol benzoate (es
trogen) or oil, rats anesthetized with Saffan (alphaxolone/alphadolone
) underwent pituitary stalk exposure and hypophysectomy, after which p
ituitary portal blood was continuously collected and stored in 15 min
aliquots from 1100-1400 h. At 1100 h, animals were given an initial bo
lus iv injection of naloxone or saline (naloxone, 2 mg/kg, or saline,
0.1 ml) and then infused (iv) continuously with naloxone (2 mg/kg/h) o
r saline (0.8 ml/h) until 1400 h. Plasma samples were extracted and as
sayed by radioimmunoassay for beta-endorphin. Treatment with estrogen
increased the mean beta-endorphin levels twofold as compared to oil-tr
eated controls. Naloxone potentiated estrogen action of beta-endorphin
secretion, but did not affect basal beta-endorphin secretion. These r
esults suggest that estrogen enhanced beta-endorphin secretion from th
e hypothalamus. Furthermore, the hypersecretion of beta-endorphin indu
ced by naloxone with, but not without, estrogen supports the existence
of an estrogen-activated short-loop negative feedback mechanism regul
ating beta-endorphin secretion.